BIOPRAZOL 20 MG
Therapeutic area
Gastro-Intestinal
Manufacturer
Inbiotech, Bulgari
Visa Number
VN-23228-22
Issuing date
11/11/2022
Applicant company
INBIOTECH
Active ingredient
Omeprazole pellet
Indication
Adults
• Prevention of relapse of duodenal, gastric ulcers
• Treatment of gastric ulcers
• In combination with appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease
• Treatment and prevention of NSAID-associated gastric and duodenal ulcers in patients at risk
• Long-term management of patients with healed reflux oesophagitis
• Treatment of symptomatic gastro-oesophageal reflux disease
• Treatment of Zollinger-Ellison syndrome
Paediatric use
Children over 1 year of age and ≥ 10 kg
• Treatment of reflux oesophagitis
• Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease
Children and adolescents over 4 years of age
• In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori.
Dosage
N/A
Content
20mg
Shelf life
36
Dosage Form
Hard capsule contains enteric-coated pellets
Package
Box of 1 bottle of 14 capsules; 28 capsules